Academic - Publications

Abstracts 2 1 2 3 4 5 6 < PreviousNext >

A16 Pandyan AD, Price C, Rodgers H, Curless R, Barnes MP, Johnson GR. Can quantifying resistance to passive movement provide a valid measure of spasticity?  Proceedings of Bioengineering in the North East, University of Durham, 1998

A17 Semlyen, JK, Barnes MP, Makepeace, R. Effectiveness of a community multiple sclerosis team. Neurorehabilitation & Neural Repair 1999; 13(1): 75

A18  Semlyen JK, Summers SJ, Barnes MP. The Newcastle Independence Assessment Form: precision and prediction. Neurorehabilitation & Neural Repair 1999; 13(1): 24

A19 Pandyan AD, Price CIM, Curless R, Barnes MP, Johnson GR. The Ashworth scales: are they valid and reliable measures of spasticity? Neurorehabilitation & Neural Repair 1999; 13(1): 58

A20 Pandyan AD, Price CIM, Curless R, Barnes MP, Johnson GR. A simple technique to quantify resistance to passive movement: a first step towards developing an objective clinical measure of spasticity. Neurorehabilitation & Neural Repair 1999; 13(1): 58

A21 Semlyen JK, Kent RM, Barnes MP. The impact of spasticity on disability in MS.
Neurorehabilitation & Neural Repair 1999; 13(1): 75

A22 Barnes MP, Whitaker J. Botulinum toxin treatment for people with dystonia treated by an outreach nurse practitioner. Neurorehabilitation & Neural Repair 1999; 13(1): 74

A23 Kent RM, Chandler BJ, Barnes MP. Service provision for disabled people living in a rural environment. Neurorehabilitation & Neural Repair 1999; 13(1): 72

A24 Kent RM, Barnes MP. Transport needs of disabled people living in a rural environment. Neurorehabilitation & Neural Repair 1999; 13(1): 71

A25 Pandyan AD, Price CIM, Barnes MP, Johnson GR. Assessing resistance to passive movement: Are repeated measures necessary? Eur J Neurol 1999; 6(Suppl3): 66

A26 Cullis PA, Barnes MP, Duane D et al. Safety and tolerability of repeat doses of NeuroBlocTM (botulinum toxin Type B) in patients with cervical dystonia: an open label, dose escalation study. 
Movement Disorders 2000; 15(Suppl 2) p29-30

A27 Barnes MP.  Extended ADL scales and quality of life measures in stroke.
Eur J Neurol 2000; 7(Suppl 3): 146